I Miyashiro, H Furukawa, M Sasako, S Yamamoto… - Gastric Cancer, 2011 - Springer Abstract Purpose To evaluate the survival benefit of adjuvant chemotherapy after curative resection in serosa-positive gastric cancer, a multicenter phase III clinical trial was conducted in Japan. Patients and methods From January 1993 to March 1998, 268 patients were ... Related articles - All 2 versions
N Piché, FA Leblond, L Sidéris, V Pichette… - Annals of …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Related articles - All 4 versions
[HTML] from thejgo.orgM Bouchereau, MK Gervais, L Sideris… - Journal of …, 2011 - thejgo.org Cytoreductive surgery(CS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is now becoming a standard of care for peritoneal carcinomatosis (PC) in selected patients. Eradication of macroscopic disease (nodules > 2.5 mm) is realized through meticulous CS. Following CS, ... Related articles - Cached - All 7 versions
M Cifuentes, M Pérez-Martín, JM Grondona… - Journal of Neuroscience …, 2011 - Elsevier Bromodeoxyuridine (BrdU) is the most widely used marker to detect proliferative cells in the adult brain. Here we analyse whether the route of administration of the tracer influences the number of labelled cells. For the intraperitoneal (ip) administration of BrdU, we performed two ...
EN Parson, S Lentz, G Russell, P Shen… - The American Journal of …, 2011 - Elsevier Few data exist on the treatment of peritoneal surface dissemination (PSD) from ovarian cancer (OC) with hyperthermic intraperitoneal chemotherapy (HIPEC). This work represents a review of the authors' institution's experience with HIPEC for PSD from OC. Related articles - All 2 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
